Upload Avatar (500 x 500)
Song Yong
Medical School
Nanjing University
Jiangsu
Language: Chinese, English
Lung Cancer: Oncology
Thoracic
Carcinoma
Metastasis
Chemotherapy
Radiotherapy
Immunotherapy
Biomarkers
Surgery
Prognosis
Acute Lung Injury: Inflammation
Ards
Ventilation
Cytokines
Hypoxia
Fibrosis
Edema
Sepsis
Trauma
Oxidative Stress
Respiratory Critical Care: Icu
Mechanical Ventilation
Respiratory Failure
Pneumonia
Sedation
Weaning
Tracheostomy
Critical Care
Areas of Focus
- Lung Cancer
- Acute Lung Injury
- Respiratory Critical Care
Work Experience
- 2020 - Director of the newly established Intensive Care Unit 2 and Expert Group Leader at Taikang Tongji (Wuhan) Hospital during the COVID-19 outbreak
- 2022 - Expert Group Leader at Shanghai National Exhibition and Convention Center Fangcang Hospital during the COVID-19 outbreak
Academic Background & Achievements
- Doctoral supervisor at Nanjing University, Naval Medical University, Nanjing Medical University
- Published over 200 research papers, including more than 100 SCI papers
- Authored and translated 6 monographs
- Participated in the formulation of multiple guidelines and consensuses
Publications
- PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/beta-catenin signaling pathway, Song Yong, 2017
- The biology, function and clinical implications of exosomes in lung cancer, Song Yong, 2017
- Pulmonary ground-glass opacity: computed tomography features, histopathology and molecular pathology, Song Yong, 2017
- Evaluation of rare but severe immune related adverse effects in PD-1 and PD-L1 inhibitors in non-small cell lung cancer: a meta-analysis, Song Yong, 2017
- RNA sequencing enables systematic identification of platelet transcriptomic alterations in NSCLC patients, Song Yong, 2018
- Three new disease-progression modes in NSCLC patients after EGFR-TKI treatment by next-generation sequencing analysis, Song Yong, 2018
- Overexpression of geranylgeranyl diphosphate synthase contributes to tumour metastasis and correlates with poor prognosis of lung adenocarcinoma, Song Yong, 2018
- Diagnostic and therapeutic value of progastrin-releasing peptide on small-cell lung cancer: A Single-Center Experience in China, Song Yong, 2018
- The association of PD-L1 expression with the efficacy of anti-PD-1/PD-L1 immunotherapy and survival of non-small cell lung cancer patients: a meta-analysis of randomized controlled trials, Song Yong, 2019
- 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis of benign pulmonary lesions in sarcoidosis, Song Yong, 2019
- Prognostic role of pretreatment neutrophil-to-lymphocyte ratio in non-small cell lung cancer patients treated with systemic therapy: a meta-analysis, Song Yong, 2019
- Treatment of uncommon mutations in non-small cell lung cancer: new evidence and treatment, Song Yong, 2019
- Irinotecan, topotecan, paclitaxel or docetaxel for second-line treatment of small cell lung cancer: a single-center retrospective study of efficiency comparation and prognosis analysis, Song Yong, 2019
- Tumor-derived exosomal lncRNA GAS5 as a biomarker for early-stage non-small-cell lung cancer diagnosis, Song Yong, 2019
- WNT5B exerts oncogenic effects and is negatively regulated by miR-5587-3p in lung adenocarcinoma progression, Song Yong, 2020
- Geranylgeranyl diphosphate synthase 1 knockout ameliorates ventilator-induced lung injury via regulation of TLR2/4-AP-1 signaling, Song Yong, 2020
- Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohort, Song Yong, 2020
- Comparison between closed pleural biopsy and medical thoracoscopy for the diagnosis of undiagnosed exudative pleural effusions: a systematic review and meta-analysis, Song Yong, 2020
- Pemetrexed-based chemotherapy for non-small-cell lung cancer patients with EGFR exon 20 insertion mutation: a multicenter study, Song Yong, 2020
- A narrative review of progress in diagnosis and treatment of small cell lung cancer patients with hyponatremia, Song Yong, 2020
- Targeting the ubiquitination/deubiquitination process to regulate immune checkpoint pathways, Song Yong, 2021
- Low-dose carboplatin reprograms tumor immune microenvironment through STING signaling pathway and synergizes with PD-1 inhibitors in lung cancer, Song Yong, 2021
- Intrapleural Injection of Anti-PD1 Antibody: A Novel Management of Malignant Pleural Effusion, Song Yong, 2021
- CD39+ Regulatory T cells attenuate lipopolysaccharide-induced acute lung injury via autophagy and the ERK/FOS pathway, Song Yong, 2021
- Pseudogene KRT17P3 drives cisplatin resistance of human NSCLC cells by modulating miR-497-5p/mTOR, Song Yong, 2021
- Novel risk scoring system for immune checkpoint inhibitors treatment in non-small cell lung cancer, Song Yong, 2021
- Clinical types of checkpoint inhibitor-related pneumonitis in lung cancer patients: a multicenter experience, Song Yong, 2021
- The prognostic value of longitudinal circulating tumor DNA profiling during osimertinib treatment, Song Yong, 2021
- Effect of Adjuvant Chemotherapy on Survival of Patients With 8th Edition Stage IB Non-Small Cell Lung Cancer, Song Yong, 2022
- Comprehensive Analysis of the Immune Microenvironment in Checkpoint Inhibitor Pneumonitis, Song Yong, 2022
Awards
- Jiangsu Provincial Science and Technology Award First Prize (2021): Establishment and promotion of an innovative platform for lung cancer diagnosis and treatment
- Ministry of Education Science and Technology Progress Award Second Prize (2017): Translational research and clinical application of precision diagnosis and treatment of non-small cell lung cancer
- National Science and Technology Progress Award Second Prize (2017): Establishment and promotion of a molecular targeted precision treatment model for lung cancer
- Jiangsu Provincial Medical Technology Introduction Award Second Prize (2020): Application of long non-coding RNA in early diagnosis, prognosis, and pathogenesis of non-small cell lung cancer
- Third Class Merit (2020): Wuxi Joint Logistics Support Center
- Third Class Merit (2011): Former Nanjing Military Region Joint Logistics Department
